Mosharraf Sarker

Dr. Mosharraf Sarker

School of Science and Engineering, Teesside University, Middlesbrough TS1 3BA, UK
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Safety Science
Verified
Journal Article
Closed access
MPMasum A. Patwary
Masum A. Patwary
WOWilliam Thomas O’hare
William Thomas O’hare
Mosharraf SarkerMosharraf Sarker
Mosharraf Sarker

1 August 2009 in Waste Management
Verified
Journal Article
Closed access
MPMasum A. Patwary
Masum A. Patwary
WOWilliam Thomas O’hAre
William Thomas O’hAre
GSGraham Street
Graham Street
KEK. Maudood Elahi
K. Maudood Elahi
SHSyed Shahadat Hossain
Syed Shahadat Hossain
Mosharraf SarkerMosharraf Sarker
Mosharraf Sarker

1 September 2014 in Developmental Cell
Verified
Journal Article
Open access
NHNatalie Hudson
Natalie Hudson
MPMichael B Powner
Michael B Powner
Mosharraf SarkerMosharraf Sarker
Mosharraf Sarker
TBThomas Burgoyne
Thomas Burgoyne
MCMatthew Campbell
Matthew Campbell
Patric TurowskiPatric Turowski
Patric Turowski
The vascular endothelium operates in a highly polarized environment, but to date there has been little exploration of apicobasal polarization of its signaling. We show that VEGF-A, histamine, IGFBP3, and LPA trigger unequal endothelial responses when acting from the circulation or the parenchymal side at blood-neural barriers. For VEGF-A, highly polarized receptor distribution contributed to distinct signaling patterns: VEGFR2, which was found to be predominantly abluminal, mediated increased permeability via p38; in contrast, luminal VEGFR1 led to Akt activation and facilitated cytoprotection. Importantly, such differential apicobasal signaling and VEGFR distribution were found in the microvasculature of brain and retina but not lung, indicating that endothelial cells at blood-neural barriers possess specialized signaling compartments that assign different functions depending on whether an agonist is tissue or blood borne.

22 October 2021 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
CECarolina Estevao
Carolina Estevao
CBChantelle E. Bowers
Chantelle E. Bowers
DLDing Luo
Ding Luo
Mosharraf SarkerMosharraf Sarker
Mosharraf Sarker
AHAlexandra Eva Hoeh
Alexandra Eva Hoeh
JGJohn Greenwood
John Greenwood
During neuroinflammation many chemokines alter the function of the blood-brain barrier (BBB) that regulates the entry of macromolecules and immune cells into the brain. As the milieu of the brain is altered, biochemical and structural changes contribute to the pathogenesis of neuroinflammation and may impact on neurogenesis. The chemokine CCL4, previously known as MIP-1β, is upregulated in a wide variety of central nervous system disorders, including multiple sclerosis, where it is thought to play a key role in the neuroinflammatory process. However, the effect of CCL4 on BBB endothelial cells (ECs) is unknown. Expression and distribution of CCR5, phosphorylated p38, F-actin, zonula occludens-1 (ZO-1) and vascular endothelial cadherin (VE-cadherin) were analysed in the human BBB EC line hCMEC/D3 by Western blot and/or immunofluorescence in the presence and absence of CCL4. Barrier modulation in response to CCL4 using hCMEC/D3 monolayers was assessed by measuring molecular flux of 70 ​kDa RITC-dextran and transendothelial lymphocyte migration. Permeability changes in response to CCL4 in vivo were measured by an occlusion technique in pial microvessels of Wistar rats and by fluorescein angiography in mouse retinae. CCR5, the receptor for CCL4, was expressed in hCMEC/D3 cells. CCL4 stimulation led to phosphorylation of p38 and the formation of actin stress fibres, both indicative of intracellular chemokine signalling. The distribution of junctional proteins was also altered in response to CCL4: junctional ZO-1 was reduced by circa 60% within 60 ​min. In addition, surface VE-cadherin was redistributed through internalisation. Consistent with these changes, CCL4 induced hyperpermeability in vitro and in vivo and increased transmigration of lymphocytes across monolayers of hCMEC/D3 cells. These results show that CCL4 can modify BBB function and may contribute to disease pathogenesis.

1 November 2011 in Journal of Environmental Management
Verified
Journal Article
Closed access
MPMasum A. Patwary
Masum A. Patwary
WOWilliam Thomas O’hAre
William Thomas O’hAre
Mosharraf SarkerMosharraf Sarker
Mosharraf Sarker

1 October 2000 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
Mosharraf SarkerMosharraf Sarker
Mosharraf Sarker
DHD.‐E. Hu
D.‐E. Hu
PFPaul Fraser
Paul Fraser